Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medicinova (MNOV)
:MNOV
Holding MNOV?
Track your performance easily
MNOV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.12 - $2.55
Previous CloseN/A
Volume15.80K
Average Volume (3M)38.88K
Market Cap
$91.72M
Enterprise ValueN/A
Total Cash (Recent Filing)$24.12M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.57
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding49,046,246
10 Day Avg. Volume33,263
30 Day Avg. Volume38,880
Standard Deviation0.13
R-Squared0.11
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)89.75
Price to Cash Flow (P/CF)-11.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$9.00Price Target Upside391.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Medicinova News
Ownership Overview
2.88%
Insiders
2.51% Mutual Funds
2.64% Other Institutional Investors
90.47% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
MNOV FAQ
What was Medicinova’s price range in the past 12 months?
Medicinova lowest stock price was $1.12 and its highest was $2.55 in the past 12 months.
What is Medicinova’s market cap?
Medicinova’s market cap is $91.72M.
When is Medicinova’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Medicinova’s earnings last quarter?
Medicinova released its earnings results on Jul 27, 2022. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of -$0.087 by -$0.063.
Is Medicinova overvalued?
According to Wall Street analysts Medicinova’s price is currently Undervalued.
Does Medicinova pay dividends?
Medicinova does not currently pay dividends.
What is Medicinova’s EPS estimate?
Medicinova’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medicinova have?
Medicinova has 49,046,246 shares outstanding.
What happened to Medicinova’s price movement after its last earnings report?
Medicinova reported an EPS of -$0.15 in its last earnings report, missing expectations of -$0.087. Following the earnings report the stock price went down -1.835%.
Which hedge fund is a major shareholder of Medicinova?
Currently, no hedge funds are holding shares in MNOV
---
Medicinova Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.00 (391.80% Upside)
$9.00 (391.80% Upside)
Blogger Sentiment
Bullish
MNOV Sentiment 70%
Sector Average 71%
Sector Average 71%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.00%
12-Months-Change
Fundamentals
Return on Equity
-17.19%
Trailing 12-Months
Asset Growth
-14.70%
Trailing 12-Months
Company Description
Medicinova
MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need. Its development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.
---
MNOV Stock 12 Month Forecast
Average Price Target
$9.00
▲(391.80% Upside)
Technical Analysis
ANI Pharmaceuticals
―
EyePoint Pharmaceuticals
―
Immutep
―
Kiniksa Pharmaceuticals
―
Phio Pharmaceuticals
―
Gritstone bio
―
Best Analysts Covering MNOV
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-16.30%
initiated a buy rating 2 months ago
Copying Jason Kolbert's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -16.30% per trade.
---